Participants
Subjects were 15 pharmacoresistant, surgically non-treatable epilepsy patients (Mage = 36.9 years, range: 17–64; 7 females) participating in the ANT deep brain stimulation (DBS) protocol at the National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary. Clinical and demographic data are reported in Table 1. The research was approved by the ethical committee of the National Institute of Mental Health, Neurology and Neurosurgery. Patients signed informed consent for participating in the study. General intelligence (IQ) was measured prior to the surgery by Wechsler Adult Intelligence Scales, 4th edition IQ from 11 patients who underwent on neuropsychological testing in the context of their clinical routine presurgical assessment.